Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HERBALIFE LTD.HLF · Entity 4842 | Director | February 28, 2018 | March 02, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HERBALIFE LTD.
Report date February 28, 2018 · Filed March 02, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,087 |
Reported balance
After 2018-02-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-02-28 · Exercise / conversion · Acquired 7,503 · Balance 11,087 F1: The reporting person received 3,854 shares of common stock upon the net exercise of the 7,503 stock appreciation rights ("SARs"). The reporting person forfeited 3,649 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. F2: Amount of securities beneficially owned following the reported transaction was corrected to add 1,665 shares previously disclosed on the reporting person's Form 4 filed on May 9, 2017. |
| Common StockSEC Table I · non-derivative | Direct | 7,438 |
Reported balance
After 2018-02-28 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2018-02-28 · Disposition to issuer · Disposed 3,649 · Balance 7,438 F1: The reporting person received 3,854 shares of common stock upon the net exercise of the 7,503 stock appreciation rights ("SARs"). The reporting person forfeited 3,649 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. |
| Common StockSEC Table I · non-derivative | Direct | 11,964 |
Reported balance
After 2018-02-28 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2018-02-28 · Exercise / conversion · Acquired 4,526 · Balance 11,964 F3: The reporting person received 615 shares of common stock upon the net exercise of the 4,526 SARs. The reporting person forfeited 3,911 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. |
| Common StockSEC Table I · non-derivative | Direct | 8,053 |
Reported balance
After 2018-02-28 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2018-02-28 · Disposition to issuer · Disposed 3,911 · Balance 8,053 F3: The reporting person received 615 shares of common stock upon the net exercise of the 4,526 SARs. The reporting person forfeited 3,911 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. |
| Common StockSEC Table I · non-derivative | Direct | 4,253 |
Reported balance
After 2018-03-02 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2018-03-02 · Sale · Disposed 3,800 · Balance 4,253 |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $44.79 · Expires 2022-05-31 | Direct | 0 |
Reported balance
After 2018-02-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-02-28 · Exercise / conversion · Disposed 7,503 · Balance 0 F1: The reporting person received 3,854 shares of common stock upon the net exercise of the 7,503 stock appreciation rights ("SARs"). The reporting person forfeited 3,649 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $79.58 · Expires 2023-12-19 | Direct | 0 |
Reported balance
After 2018-02-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-02-28 · Exercise / conversion · Disposed 4,526 · Balance 0 F3: The reporting person received 615 shares of common stock upon the net exercise of the 4,526 SARs. The reporting person forfeited 3,911 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received 3,854 shares of common stock upon the net exercise of the 7,503 stock appreciation rights ("SARs"). The reporting person forfeited 3,649 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10.
F2: Amount of securities beneficially owned following the reported transaction was corrected to add 1,665 shares previously disclosed on the reporting person's Form 4 filed on May 9, 2017.
F3: The reporting person received 615 shares of common stock upon the net exercise of the 4,526 SARs. The reporting person forfeited 3,911 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2018 Filed Mar 2, 2018 23:45 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 3,800 | $91.77 | $348,726.00 |
DisclosureSEC source: 0001209191-18-016000 · doc4.xml · nonDerivative · entry 5 Bermingham Richard P · CIK 0001301747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,253 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 23:45 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 4,526 | $0.00 Strike: $79.58 | $0.00 |
DisclosureSEC source: 0001209191-18-016000 · doc4.xml · derivative · entry 7 Bermingham Richard P · CIK 0001301747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,526 shares Expires 2023-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The reporting person received 615 shares of common stock upon the net exercise of the 4,526 SARs. The reporting person forfeited 3,911 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 23:45 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 7,503 | $0.00 Strike: $44.79 | $0.00 |
DisclosureSEC source: 0001209191-18-016000 · doc4.xml · derivative · entry 6 Bermingham Richard P · CIK 0001301747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,503 shares Expires 2022-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person received 3,854 shares of common stock upon the net exercise of the 7,503 stock appreciation rights ("SARs"). The reporting person forfeited 3,649 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 23:45 UTC | HERBALIFE LTD. HLF · Entity 4842 | Disposition to issuerCommon Stock | 3,911 | $92.10 | $360,203.10 |
DisclosureSEC source: 0001209191-18-016000 · doc4.xml · nonDerivative · entry 4 Bermingham Richard P · CIK 0001301747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,053 F3 · kind: The reporting person received 615 shares of common stock upon the net exercise of the 4,526 SARs. The reporting person forfeited 3,911 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 23:45 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 4,526 | $79.58 | $360,179.08 |
DisclosureSEC source: 0001209191-18-016000 · doc4.xml · nonDerivative · entry 3 Bermingham Richard P · CIK 0001301747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The reporting person received 615 shares of common stock upon the net exercise of the 4,526 SARs. The reporting person forfeited 3,911 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 23:45 UTC | HERBALIFE LTD. HLF · Entity 4842 | Disposition to issuerCommon Stock | 3,649 | $92.10 | $336,072.90 |
DisclosureSEC source: 0001209191-18-016000 · doc4.xml · nonDerivative · entry 2 Bermingham Richard P · CIK 0001301747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,438 F1 · kind: The reporting person received 3,854 shares of common stock upon the net exercise of the 7,503 stock appreciation rights ("SARs"). The reporting person forfeited 3,649 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 23:45 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 7,503 | $44.79 | $336,059.37 |
DisclosureSEC source: 0001209191-18-016000 · doc4.xml · nonDerivative · entry 1 Bermingham Richard P · CIK 0001301747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person received 3,854 shares of common stock upon the net exercise of the 7,503 stock appreciation rights ("SARs"). The reporting person forfeited 3,649 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. F2 · balance_after: Amount of securities beneficially owned following the reported transaction was corrected to add 1,665 shares previously disclosed on the reporting person's Form 4 filed on May 9, 2017. Read SEC document |
| May 10, 2017 Filed May 12, 2017 00:37 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 7,510 | $72.92 | $547,629.20 |
DisclosureSEC source: 0001209191-17-031685 · doc4.xml · nonDerivative · entry 1 Bermingham Richard P · CIK 0001301747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,919 F1 · price: This transaction was executed in multiple trades at prices ranging from $72.90 to $72.94. The price reported reflects the weighted average sale price of $72.92. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 08, 2017 Filed May 10, 2017 00:26 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031100 · doc4.xml · nonDerivative · entry 2 Bermingham Richard P · CIK 0001301747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,094 F2 · kind: Consists of restricted stock units under the Herbalife Ltd. 2014 Stock Incentive Plan. This award will vest 100% on April 15, 2018. Read SEC document |
| May 05, 2017 Filed May 10, 2017 00:26 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 12,000 | $67.00 | $804,000.00 |
DisclosureSEC source: 0001209191-17-031100 · doc4.xml · nonDerivative · entry 1 Bermingham Richard P · CIK 0001301747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,429 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.